MDCT  ||| S:0 E:5 ||| NNP
venography  ||| S:5 E:16 ||| NN
in  ||| S:16 E:19 ||| IN
patients  ||| S:19 E:28 ||| NNS
with  ||| S:28 E:33 ||| IN
suspected  ||| S:33 E:43 ||| JJ
pulmonary  ||| S:43 E:53 ||| JJ
embolism ||| S:53 E:61 ||| NN
:  ||| S:61 E:63 ||| :
diagnostic  ||| S:63 E:74 ||| JJ
impact  ||| S:74 E:81 ||| NN
of  ||| S:81 E:84 ||| IN
pelvic  ||| S:84 E:91 ||| JJ
vein  ||| S:91 E:96 ||| NN
evaluation  ||| S:96 E:107 ||| NN
in  ||| S:107 E:110 ||| IN
thromboembolic  ||| S:110 E:125 ||| JJ
disease  ||| S:125 E:133 ||| NN
detection  ||| S:133 E:143 ||| NN
To  ||| S:143 E:146 ||| TO
assess  ||| S:146 E:153 ||| VB
the  ||| S:153 E:157 ||| DT
incremental  ||| S:157 E:169 ||| JJ
value  ||| S:169 E:175 ||| NN
of  ||| S:175 E:178 ||| IN
pelvic  ||| S:178 E:185 ||| JJ
vein-evaluation  ||| S:185 E:201 ||| NN
with  ||| S:201 E:206 ||| IN
Multidetector  ||| S:206 E:220 ||| NNP
CT  ||| S:220 E:223 ||| NNP
Venography  ||| S:223 E:234 ||| NNP
( ||| S:234 E:235 ||| -LRB-
MDCT-V ||| S:235 E:241 ||| NNP
)  ||| S:241 E:243 ||| -RRB-
for  ||| S:243 E:247 ||| IN
the  ||| S:247 E:251 ||| DT
diagnosis  ||| S:251 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
thromboembolic  ||| S:264 E:279 ||| JJ
disease  ||| S:279 E:287 ||| NN
in  ||| S:287 E:290 ||| IN
patients  ||| S:290 E:299 ||| NNS
suspected  ||| S:299 E:309 ||| VBN
of  ||| S:309 E:312 ||| IN
Pulmonary  ||| S:312 E:322 ||| NNP
Embolism  ||| S:322 E:331 ||| NNP
( ||| S:331 E:332 ||| -LRB-
PE ||| S:332 E:334 ||| NNP
) ||| S:334 E:335 ||| -RRB-
.  ||| S:335 E:337 ||| .
We  ||| S:337 E:340 ||| PRP
retrospectively  ||| S:340 E:356 ||| VBP
reviewed  ||| S:356 E:365 ||| VBN
CT  ||| S:365 E:368 ||| NNP
images  ||| S:368 E:375 ||| NNS
of  ||| S:375 E:378 ||| IN
440  ||| S:378 E:382 ||| CD
patients  ||| S:382 E:391 ||| NNS
( ||| S:391 E:392 ||| -LRB-
228  ||| S:392 E:396 ||| CD
women  ||| S:396 E:402 ||| NNS
and  ||| S:402 E:406 ||| CC
212  ||| S:406 E:410 ||| CD
men ||| S:410 E:413 ||| NNS
;  ||| S:413 E:415 ||| :
mean  ||| S:415 E:420 ||| JJ
age  ||| S:420 E:424 ||| NN
63  ||| S:424 E:427 ||| CD
Â±  ||| S:427 E:429 ||| CD
18  ||| S:429 E:432 ||| CD
years ||| S:432 E:437 ||| NNS
)  ||| S:437 E:439 ||| -RRB-
who  ||| S:439 E:443 ||| WP
underwent  ||| S:443 E:453 ||| VBD
combined  ||| S:453 E:462 ||| VBN
Multidetector  ||| S:462 E:476 ||| NNP
CT  ||| S:476 E:479 ||| NNP
Pulmonary  ||| S:479 E:489 ||| NNP
Angiography  ||| S:489 E:501 ||| NNP
( ||| S:501 E:502 ||| -LRB-
MDCT-PA ||| S:502 E:509 ||| NNP
)  ||| S:509 E:511 ||| -RRB-
and  ||| S:511 E:515 ||| CC
MDCT-V  ||| S:515 E:522 ||| JJ
for  ||| S:522 E:526 ||| IN
suspected  ||| S:526 E:536 ||| JJ
PE ||| S:536 E:538 ||| NNP
.  ||| S:538 E:540 ||| .
Frequency  ||| S:540 E:550 ||| NN
of  ||| S:550 E:553 ||| IN
PE ||| S:553 E:555 ||| NNP
,  ||| S:555 E:557 ||| ,
deep  ||| S:557 E:562 ||| JJ
venous  ||| S:562 E:569 ||| JJ
thrombosis  ||| S:569 E:580 ||| NNS
( ||| S:580 E:581 ||| -LRB-
DVT ||| S:581 E:584 ||| NNP
) ||| S:584 E:585 ||| -RRB-
,  ||| S:585 E:587 ||| ,
and  ||| S:587 E:591 ||| CC
venous  ||| S:591 E:598 ||| JJ
thromboembolism  ||| S:598 E:614 ||| NNS
( ||| S:614 E:615 ||| -LRB-
VTE ||| S:615 E:618 ||| NNP
)  ||| S:618 E:620 ||| -RRB-
were  ||| S:620 E:625 ||| VBD
assessed  ||| S:625 E:634 ||| VBN
together  ||| S:634 E:643 ||| RP
with  ||| S:643 E:648 ||| IN
the  ||| S:648 E:652 ||| DT
incremental  ||| S:652 E:664 ||| JJ
value  ||| S:664 E:670 ||| NN
of  ||| S:670 E:673 ||| IN
MDCT-V ||| S:673 E:679 ||| JJ
;  ||| S:679 E:681 ||| :
the  ||| S:681 E:685 ||| DT
distribution  ||| S:685 E:698 ||| NN
of  ||| S:698 E:701 ||| IN
thrombi  ||| S:701 E:709 ||| NN
and  ||| S:709 E:713 ||| CC
the  ||| S:713 E:717 ||| DT
frequency  ||| S:717 E:727 ||| NN
of  ||| S:727 E:730 ||| IN
isolated  ||| S:730 E:739 ||| JJ
clots  ||| S:739 E:745 ||| NN
in  ||| S:745 E:748 ||| IN
the  ||| S:748 E:752 ||| DT
inferior  ||| S:752 E:761 ||| JJ
vena  ||| S:761 E:766 ||| JJ
cava  ||| S:766 E:771 ||| NN
or  ||| S:771 E:774 ||| CC
iliac  ||| S:774 E:780 ||| JJ
veins  ||| S:780 E:786 ||| NN
were  ||| S:786 E:791 ||| VBD
also  ||| S:791 E:796 ||| RB
recorded  ||| S:796 E:805 ||| VBN
for  ||| S:805 E:809 ||| IN
each  ||| S:809 E:814 ||| DT
patient ||| S:814 E:821 ||| NN
.  ||| S:821 E:823 ||| .
PE  ||| S:823 E:826 ||| NNP
was  ||| S:826 E:830 ||| VBD
detected  ||| S:830 E:839 ||| VBN
in  ||| S:839 E:842 ||| IN
146  ||| S:842 E:846 ||| CD
( ||| S:846 E:847 ||| -LRB-
33 ||| S:847 E:849 ||| CD
% ||| S:849 E:850 ||| NN
)  ||| S:850 E:852 ||| -RRB-
of  ||| S:852 E:855 ||| IN
440  ||| S:855 E:859 ||| CD
patients ||| S:859 E:867 ||| NNS
,  ||| S:867 E:869 ||| ,
DVT  ||| S:869 E:873 ||| NNP
in  ||| S:873 E:876 ||| IN
147  ||| S:876 E:880 ||| CD
( ||| S:880 E:881 ||| -LRB-
33.4 ||| S:881 E:885 ||| NNP
% ||| S:885 E:886 ||| NN
)  ||| S:886 E:888 ||| -RRB-
and  ||| S:888 E:892 ||| CC
VTE  ||| S:892 E:896 ||| NNP
in  ||| S:896 E:899 ||| IN
196  ||| S:899 E:903 ||| CD
( ||| S:903 E:904 ||| -LRB-
44 ||| S:904 E:906 ||| CD
% ||| S:906 E:907 ||| NN
) ||| S:907 E:908 ||| -RRB-
.  ||| S:908 E:910 ||| .
MDCT-V  ||| S:910 E:917 ||| NNP
showed  ||| S:917 E:924 ||| VBD
thrombi  ||| S:924 E:932 ||| VBN
in  ||| S:932 E:935 ||| IN
50  ||| S:935 E:938 ||| CD
patients  ||| S:938 E:947 ||| NNS
who  ||| S:947 E:951 ||| WP
did  ||| S:951 E:955 ||| VBD
not  ||| S:955 E:959 ||| RB
have  ||| S:959 E:964 ||| VB
signs  ||| S:964 E:970 ||| NNS
of  ||| S:970 E:973 ||| IN
PE  ||| S:973 E:976 ||| NNP
at  ||| S:976 E:979 ||| IN
MDCT-PA ||| S:979 E:986 ||| JJ
.  ||| S:986 E:988 ||| .
Thus ||| S:988 E:992 ||| RB
,  ||| S:992 E:994 ||| ,
the  ||| S:994 E:998 ||| DT
addition  ||| S:998 E:1007 ||| NN
of  ||| S:1007 E:1010 ||| IN
MDCT-V  ||| S:1010 E:1017 ||| NNP
resulted  ||| S:1017 E:1026 ||| VBD
in  ||| S:1026 E:1029 ||| IN
a  ||| S:1029 E:1031 ||| DT
25 ||| S:1031 E:1033 ||| CD
%  ||| S:1033 E:1035 ||| NN
increase  ||| S:1035 E:1044 ||| NN
in  ||| S:1044 E:1047 ||| IN
thromboembolic  ||| S:1047 E:1062 ||| JJ
disease  ||| S:1062 E:1070 ||| NN
detection  ||| S:1070 E:1080 ||| NNS
( ||| S:1080 E:1081 ||| -LRB-
99 ||| S:1081 E:1083 ||| CD
%  ||| S:1083 E:1085 ||| NN
confidence  ||| S:1085 E:1096 ||| NN
interval ||| S:1096 E:1104 ||| NNS
:  ||| S:1104 E:1106 ||| :
22 ||| S:1106 E:1108 ||| CD
% ||| S:1108 E:1109 ||| NN
,  ||| S:1109 E:1111 ||| ,
28 ||| S:1111 E:1113 ||| CD
% ||| S:1113 E:1114 ||| NN
) ||| S:1114 E:1115 ||| -RRB-
.  ||| S:1115 E:1117 ||| .
Among  ||| S:1117 E:1123 ||| IN
147  ||| S:1123 E:1127 ||| CD
patients  ||| S:1127 E:1136 ||| NNS
with  ||| S:1136 E:1141 ||| IN
DVT ||| S:1141 E:1144 ||| NNP
,  ||| S:1144 E:1146 ||| ,
only  ||| S:1146 E:1151 ||| RB
four  ||| S:1151 E:1156 ||| CD
had  ||| S:1156 E:1160 ||| VBD
thrombi  ||| S:1160 E:1168 ||| VBN
in  ||| S:1168 E:1171 ||| IN
the  ||| S:1171 E:1175 ||| DT
iliac  ||| S:1175 E:1181 ||| NN
and ||| S:1181 E:1184 ||| CC
/ ||| S:1184 E:1185 ||| NNP
or  ||| S:1185 E:1188 ||| CC
in  ||| S:1188 E:1191 ||| IN
the  ||| S:1191 E:1195 ||| DT
inferior  ||| S:1195 E:1204 ||| JJ
vena  ||| S:1204 E:1209 ||| JJ
cava  ||| S:1209 E:1214 ||| NN
without  ||| S:1214 E:1222 ||| IN
femoral  ||| S:1222 E:1230 ||| NN
or  ||| S:1230 E:1233 ||| CC
popliteal  ||| S:1233 E:1243 ||| JJ
vein  ||| S:1243 E:1248 ||| NN
thrombosis ||| S:1248 E:1258 ||| NNS
;  ||| S:1258 E:1260 ||| :
however ||| S:1260 E:1267 ||| RB
,  ||| S:1267 E:1269 ||| ,
all  ||| S:1269 E:1273 ||| DT
but  ||| S:1273 E:1277 ||| CC
one  ||| S:1277 E:1281 ||| PRP
had  ||| S:1281 E:1285 ||| VBD
also  ||| S:1285 E:1290 ||| RB
PE  ||| S:1290 E:1293 ||| NNP
detected  ||| S:1293 E:1302 ||| VBD
on  ||| S:1302 E:1305 ||| IN
MDCT-PA ||| S:1305 E:1312 ||| JJ
.  ||| S:1312 E:1314 ||| .
Thus ||| S:1314 E:1318 ||| RB
,  ||| S:1318 E:1320 ||| ,
the  ||| S:1320 E:1324 ||| DT
diagnostic  ||| S:1324 E:1335 ||| JJ
value  ||| S:1335 E:1341 ||| NN
of  ||| S:1341 E:1344 ||| IN
MDCT  ||| S:1344 E:1349 ||| NNP
pelvic  ||| S:1349 E:1356 ||| JJ
vein  ||| S:1356 E:1361 ||| NN
evaluation  ||| S:1361 E:1372 ||| NN
was  ||| S:1372 E:1376 ||| VBD
2.7 ||| S:1376 E:1379 ||| CD
%  ||| S:1379 E:1381 ||| NN
in  ||| S:1381 E:1384 ||| IN
the  ||| S:1384 E:1388 ||| DT
diagnosis  ||| S:1388 E:1398 ||| NN
of  ||| S:1398 E:1401 ||| IN
DVT  ||| S:1401 E:1405 ||| NNP
and  ||| S:1405 E:1409 ||| CC
0.5 ||| S:1409 E:1412 ||| CD
%  ||| S:1412 E:1414 ||| NN
in  ||| S:1414 E:1417 ||| IN
the  ||| S:1417 E:1421 ||| DT
diagnosis  ||| S:1421 E:1431 ||| NN
of  ||| S:1431 E:1434 ||| IN
VTE ||| S:1434 E:1437 ||| NNP
.  ||| S:1437 E:1439 ||| .
In  ||| S:1439 E:1442 ||| IN
patients  ||| S:1442 E:1451 ||| NNS
with  ||| S:1451 E:1456 ||| IN
suspected  ||| S:1456 E:1466 ||| JJ
PE ||| S:1466 E:1468 ||| NNP
,  ||| S:1468 E:1470 ||| ,
evaluation  ||| S:1470 E:1481 ||| NN
of  ||| S:1481 E:1484 ||| IN
pelvic  ||| S:1484 E:1491 ||| JJ
veins  ||| S:1491 E:1497 ||| NN
with  ||| S:1497 E:1502 ||| IN
MDCT-V  ||| S:1502 E:1509 ||| NNP
has  ||| S:1509 E:1513 ||| VBZ
a  ||| S:1513 E:1515 ||| DT
limited  ||| S:1515 E:1523 ||| JJ
impact  ||| S:1523 E:1530 ||| NN
on  ||| S:1530 E:1533 ||| IN
the  ||| S:1533 E:1537 ||| DT
diagnosis  ||| S:1537 E:1547 ||| NN
of  ||| S:1547 E:1550 ||| IN
thromboembolic  ||| S:1550 E:1565 ||| JJ
disease  ||| S:1565 E:1573 ||| NN
and  ||| S:1573 E:1577 ||| CC
could  ||| S:1577 E:1583 ||| MD
be  ||| S:1583 E:1586 ||| VB
safely  ||| S:1586 E:1593 ||| RB
omitted ||| S:1593 E:1600 ||| VBN
.  ||| S:1600 E:1602 ||| .
